Latest filing published 09 Jul 2020 for NexgenRx Inc., €66k.
All filings by Thomas Corcoran on record concern NexgenRx Inc. We count 3 filings; the first trade dates from 28 August 2006 and the latest from 4 July 2020.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 9 July 2020: a transaction of €66k, in NexgenRx Inc. Filings reach the SEDI feed a median of 5 days after the trade. That lag is the time during which only the insider knows about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations